Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Ayles

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
The Lancet. HIV|November 4, 2022
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling studyWilliam J M Probert, Rafael Sauter, Michael Pickles, et al.
Open Forum Infectious Diseases|December 21, 2022
The Presence of Hemoglobin in Cervicovaginal Lavage Is Not Associated With Genital Schistosomiasis in Zambian Women From the BILHIV StudyAmy S Sturt, Emily L Webb, Comfort R Phiri, et al.
BMC Infectious Diseases|November 11, 2022
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatmentWendy Grant-McAuley, Oliver Laeyendecker, Daniel Monaco, et al.
BMJ Open|June 10, 2024
Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and HIV in ZambiaKwame Shanaube, Rhoda Ndubani, Helen Kelly, et al.
Open Forum Infectious Diseases|August 2, 2021
Female Genital Schistosomiasis and HIV-1 Incidence in Zambian Women: A Retrospective Cohort StudyAmy S Sturt, Emily L Webb, Comfort R Phiri, et al.
Journal of the International AIDS Society|July 12, 2022
The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South AfricaJames R Hargreaves, Triantafyllos Pliakas, Graeme Hoddinott, et al.
Open Forum Infectious Diseases|September 24, 2021
Association of Female Genital Schistosomiasis With the Cervicovaginal Microbiota and Sexually Transmitted Infections in Zambian WomenAmy S Sturt, Emily L Webb, Lisa Himschoot, et al.
Plos One|September 17, 2024
Identification of antibody targets associated with lower HIV viral load and viremic controlWendy Grant-McAuley, William R Morgenlander, Ingo Ruczinski, et al.
Frontiers in Immunology|September 25, 2023
Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral loadWendy Grant-McAuley, William Morgenlander, Sarah E Hudelson, et al.
The Lancet. Global Health|March 15, 2021
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trialRanjeeta Thomas, William J M Probert, Rafael Sauter, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
The Lancet. HIV|November 4, 2022
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling studyWilliam J M Probert, Rafael Sauter, Michael Pickles, et al.
Open Forum Infectious Diseases|December 21, 2022
The Presence of Hemoglobin in Cervicovaginal Lavage Is Not Associated With Genital Schistosomiasis in Zambian Women From the BILHIV StudyAmy S Sturt, Emily L Webb, Comfort R Phiri, et al.
BMC Infectious Diseases|November 11, 2022
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatmentWendy Grant-McAuley, Oliver Laeyendecker, Daniel Monaco, et al.
BMJ Open|June 10, 2024
Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and HIV in ZambiaKwame Shanaube, Rhoda Ndubani, Helen Kelly, et al.
Open Forum Infectious Diseases|August 2, 2021
Female Genital Schistosomiasis and HIV-1 Incidence in Zambian Women: A Retrospective Cohort StudyAmy S Sturt, Emily L Webb, Comfort R Phiri, et al.
Journal of the International AIDS Society|July 12, 2022
The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South AfricaJames R Hargreaves, Triantafyllos Pliakas, Graeme Hoddinott, et al.
Open Forum Infectious Diseases|September 24, 2021
Association of Female Genital Schistosomiasis With the Cervicovaginal Microbiota and Sexually Transmitted Infections in Zambian WomenAmy S Sturt, Emily L Webb, Lisa Himschoot, et al.
Plos One|September 17, 2024
Identification of antibody targets associated with lower HIV viral load and viremic controlWendy Grant-McAuley, William R Morgenlander, Ingo Ruczinski, et al.
Frontiers in Immunology|September 25, 2023
Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral loadWendy Grant-McAuley, William Morgenlander, Sarah E Hudelson, et al.
The Lancet. Global Health|March 15, 2021
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trialRanjeeta Thomas, William J M Probert, Rafael Sauter, et al.
Pageof 22